Additionally, dual staining for TK1/CD31 was able to more accurately identify tumor vessels in colorectal carcinoma than staining for other markers, suggesting that TK1/CD31 dual staining may be a useful predictor of tumor responses to anti-angiogenic therapy [20]. This evidence concerns the gene PECAM1 and neoplasm.